MLchartDataset catalogue

Palladium Pd-103

Term · Oncology and biomedicine · MLC-T-ONC-015779

A radioisotope of the metal palladium used in brachytherapy implants or 'seed'. With a half-life of 17 days, palladium 103 administered with brachytherapy allows continuous, tumor-site specific low-energy irradiation to the tumor cell population while sparing normal adjacent tissues from radiotoxicity.

Table 1. Record
IdentifierMLC-T-ONC-015779
FieldOncology and biomedicine
AbbreviationPd 103
Synonymspalladium 103; palladium Pd 103; palladium-103
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015779",
  "term": "Palladium Pd-103",
  "field": "Oncology and biomedicine",
  "definition": "A radioisotope of the metal palladium used in brachytherapy implants or 'seed'. With a half-life of 17 days, palladium 103 administered with brachytherapy allows continuous, tumor-site specific low-energy irradiation to the tumor cell population while sparing normal adjacent tissues from radiotoxicity.",
  "abbreviation": "Pd 103",
  "synonyms": [
    "palladium 103",
    "palladium Pd 103",
    "palladium-103"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/palladium-pd-103/"
}

Record 12,529 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.